Concord Biotech Fundamentals
P/E Ratio
37.35
P/B Ratio
6.17
Div. Yield
0.96
Sector P/E
71.81
Sector P/B
3.44
Sec. Div. Yield
0.55
Concord Biotech Fundamentals is currently trading with a P/E Ratio of 37.35, compared to the sector average of 71.81. Its P/B Ratio stands at 6.17, while the sector’s is 3.44. In terms of returns, the stock offers a Dividend Yield of 0.96%, which is than the sector’s 0.55%.
Concord Biotech Score Card
Price
Expensive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Concord Biotech reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
